KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Income from Continuing Operations (2016 - 2025)

CareDx (CDNA) has disclosed Income from Continuing Operations for 13 consecutive years, with 4108000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations fell 104.69% to 4108000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 21396000.0 through Dec 2025, down 140.75% year-over-year, with the annual reading at 21354000.0 for FY2025, 140.64% down from the prior year.
  • Income from Continuing Operations hit 4108000.0 in Q4 2025 for CareDx, down from 1675000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 87658000.0 in Q4 2024 to a low of 118097000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 13317600.0 across 5 years, with a median of 14005000.0 in 2021.
  • Biggest five-year swings in Income from Continuing Operations: crashed 2922.77% in 2022 and later soared 174.23% in 2024.
  • Year by year, Income from Continuing Operations stood at 16151000.0 in 2021, then dropped by 13.52% to 18335000.0 in 2022, then tumbled by 544.11% to 118097000.0 in 2023, then skyrocketed by 174.23% to 87658000.0 in 2024, then tumbled by 104.69% to 4108000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for CDNA at 4108000.0 in Q4 2025, 1675000.0 in Q3 2025, and 8568000.0 in Q2 2025.